Enthesitis: A hallmark of psoriatic arthritis
Open accessThe DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To describe the growing importance of enthesitis in patients with psoriatic arthritis (PsA) and discuss the advantages and disadvantages of clinical and imaging methods currently used to assess enthesitis. METHODS: PubMed literature searches were conducted using the terms psoriatic arthritis, entheses, enthesitis, pathology, imaging, ultrasound, magnetic resonance imaging, clinical, and indices. Articles were deemed relevant if they provided insight into the pathology, monitoring, and/or diagnosis of enthesitis in PsA, or if they discussed clinical or imaging indices used to assess enthesitis. RESULTS: Enthesitis is an early manifestation of PsA that is associated with increased disease activity and reduced quality of life. A variety of clinical indices exist to assess enthesitis in PsA; however, the Leeds Enthesitis Index and Maastricht Ankylosing Spondylitis Enthesitis Score index have been the most frequently used indices in recent clinical trials. Limitations of these indices include an inability to discern structural involvement, risk of missing subclinical enthesitis, and lack of sensitivity in detecting enthesitis, especially in patients with central sensitization and/or pain amplification. Such limitations have led to the emergent importance of imaging techniques in the assessment of enthesitis. Although there have been recent advances in magnetic resonance imaging, ultrasound (US) appears to be the preferred method for detecting enthesitis because it allows for accurate assessment of the soft-tissue components of entheses and also for new bone formation. Hypoechogenicity, increased thickness of tendon insertion, calcifications, enthesophytes, erosions, and Doppler activity have been identified as important US characteristics of enthesitis. CONCLUSION: Enthesitis is thought to be integrally involved in the pathogenesis of PsA and is associated with worse prognostic outcomes in patients with PsA. A validated US index with entheses that are less confounded by mechanical factors and obesity would be the most effective measure of enthesitis in PsA. As imaging techniques continue to advance, our understanding of enthesitis and its involvement in PsA will also improve.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Taylor, W., Gladman, D., Helliwell, P., Marchesoni, A., Mease, P., & Mielants, H. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21972 · Cited by 3,746 · cited 2×
“As suggested by the CASPAR criteria as well as GRAPPA recommendations, inflammation of the entheses (enthesitis) is important to the identification, diagnosis, and treatment of PsA [7,8].”
BackgroundMethodMoll, J. M. H., & Wright, V. (1973) · Seminars in Arthritis and Rheumatism · doi:10.1016/0049-0172(73)90035-8 · Cited by 1,261
IL-23 induces spondyloarthropathy by acting on ROR-γt+ CD3+CD4−CD8− entheseal resident T cells
Sherlock, J. P., Joyce-Shaikh, B., Turner, S. P., Chao, C.-C., Sathe, M., Grein, J., Gorman, D. M., Bowman, E. P., McClanahan, T. K., Yearley, J. H., et al. (2012) · Nature Medicine · doi:10.1038/nm.2817 · Cited by 1,060 · cited 4×
“A murine model has demonstrated that inflamed locations in spondyloarthropathy, such as entheses and the aortic root, contain IL-23-responsive CD3þCD4–CD8– resident cells [33].”
BackgroundInfluentialMease, P. J., Gladman, D. D., Ritchlin, C. T., Ruderman, E. M., Steinfeld, S. D., Choy, E. H. S., Sharp, J. T., Ory, P. A., Perdok, R. J., & Weinberg, M. A. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21306 · Cited by 909
Coates, L. C., Kavanaugh, A., Mease, P. J., Soriano, E. R., Laura Acosta‐Felquer, M., Armstrong, A. W., Bautista‐Molano, W., Boehncke, W., Campbell, W., Cauli, A., et al. (2016) · Arthritis & Rheumatology · doi:10.1002/art.39573 · Cited by 903 · cited 3×
“As suggested by the CASPAR criteria as well as GRAPPA recommendations, inflammation of the entheses (enthesitis) is important to the identification, diagnosis, and treatment of PsA [7,8].”
BackgroundMethodMcInnes, I. B., Mease, P. J., Kirkham, B., Kavanaugh, A., Ritchlin, C. T., Rahman, P., van der Heijde, D., Landewé, R., Conaghan, P. G., Gottlieb, A. B., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)61134-5 · Cited by 858
McInnes, I. B., Kavanaugh, A., Gottlieb, A. B., Puig, L., Rahman, P., Ritchlin, C., Brodmerkel, C., Li, S., Wang, Y., Mendelsohn, A. M., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60594-2 · Cited by 807
Guidelines of care for the management of psoriasis and psoriatic arthritis
Gottlieb, A., Korman, N. J., Gordon, K. B., Feldman, S. R., Lebwohl, M., Koo, J. Y. M., Van Voorhees, A. S., Elmets, C. A., Leonardi, C. L., Beutner, K. R., et al. (2008) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2008.02.040 · Cited by 769 · cited 1×
“Although PsA may present at any point in a patient’s life, it most commonly occurs between the ages of 30 and 50 years [2,3].”
BackgroundSecukinumab Inhibition of Interleukin-17A in Patients with Psoriatic Arthritis
Mease, P. J., McInnes, I. B., Kirkham, B., Kavanaugh, A., Rahman, P., van der Heijde, D., Landewé, R., Nash, P., Pricop, L., Yuan, J., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1412679 · Cited by 746
Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial
Antoni, C., Krueger, G. G., de Vlam, K., Birbara, C., Beutler, A., Guzzo, C., Zhou, B., Dooley, L. T., & Kavanaugh, A. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2004.032268 · Cited by 715
Ritchlin, C., Rahman, P., Kavanaugh, A., McInnes, I. B., Puig, L., Li, S., Wang, Y., Shen, Y.-K., Doyle, M. K., Mendelsohn, A. M., et al. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204655 · Cited by 662
Benjamin, M., & McGonagle, D. (2001) · Journal of Anatomy · doi:10.1046/j.1469-7580.2001.19950503.x · Cited by 651 · cited 2×
“Inflammatory entheseal changes associated with spondyloarthritis almost always occur at fibrocartilaginous attachments [9,12].”
BackgroundHaroon, M., Gallagher, P., & FitzGerald, O. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204858 · Cited by 626 · cited 1×
“A 6-month delay in the diagnosis of PsA has been linked with worse longterm radiographic and functional outcomes [75].”
BackgroundKavanaugh, A., McInnes, I., Mease, P., Krueger, G. G., Gladman, D., Gomez‐Reino, J., Papp, K., Zrubek, J., Mudivarthy, S., Mack, M., et al. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24403 · Cited by 602
Mease, P. J., van der Heijde, D., Ritchlin, C. T., Okada, M., Cuchacovich, R. S., Shuler, C. L., Lin, C.-Y., Braun, D. K., Lee, C. H., & Gladman, D. D. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-209709 · Cited by 580
Treatment recommendations for psoriatic arthritis
Ritchlin, C. T., Kavanaugh, A., Gladman, D. D., Mease, P. J., Helliwell, P., Boehncke, W.-H., de Vlam, K., Fiorentino, D., FitzGerald, O., Gottlieb, A. B., et al. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.094946 · Cited by 554
Mease, P. J., Gladman, D. D., Papp, K. A., Khraishi, M. M., Thaçi, D., Behrens, F., Northington, R., Fuiman, J., Bananis, E., Boggs, R., et al. (2013) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2013.07.023 · Cited by 508 · cited 1×
“Psoriatic arthritis (PsA) is a form of chronic inflammatory arthritis affecting nearly 30% of patients with psoriasis [1].”
BackgroundHealy, P. J., & Helliwell, P. (2008) · Arthritis Care & Research · doi:10.1002/art.23568 · Cited by 487 · cited 2×
“Further, LEI is capable of distinguishing between patients with and without active PsA [65].”
BackgroundMethodMease, P. J., Fleischmann, R., Deodhar, A. A., Wollenhaupt, J., Khraishi, M. M., Kielar, D., Woltering, F., Stach, C. M., Hoepken, B., Arledge, T., et al. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-203696 · Cited by 485
Jacques, P., Lambrecht, S., Verheugen, E., Pauwels, E., Kollias, G., Armaka, M., Verhoye, M., Van der Linden, A., Achten, R., Lories, R. J., et al. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-203643 · Cited by 431 · cited 1×
“Tumor necrosis factor (TNF) mouse models, in which there is chronic TNF production, have been used to study spondyloarthritis [27].”
BackgroundNash, P., Kirkham, B., Okada, M., Rahman, P., Combe, B., Burmester, G.-R., Adams, D. H., Kerr, L., Lee, C., Shuler, C. L., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31429-0 · Cited by 405
McGonagle, D., Lories, R. J. U., Tan, A. L., & Benjamin, M. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22758 · Cited by 398
Mease, P. J. (2011) · Arthritis Care & Research · doi:10.1002/acr.20577 · Cited by 342
Gisondi, P., Tinazzi, I., El-Dalati, G., Gallo, M., Biasi, D., Barbara, L. M., & Girolomoni, G. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.075101 · Cited by 304 · cited 7×
“The BMI of patients with PsA, however, is higher versus the general population [97], and BMI is known to have a major impact on entheseal findings.”
BackgroundInfluentialEdwards, C. J., Blanco, F. J., Crowley, J., Birbara, C. A., Jaworski, J., Aelion, J., Stevens, R. M., Vessey, A., Zhan, X., & Bird, P. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2015-207963 · Cited by 287
β‐glucan triggers spondylarthritis and Crohn's disease–like ileitis in SKG mice
Ruutu, M., Thomas, G., Steck, R., Degli‐Esposti, M. A., Zinkernagel, M. S., Alexander, K., Velasco, J., Strutton, G., Tran, A., Benham, H., et al. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34423 · Cited by 262 · cited 1×
“Additional studies using the SKG mouse models further support the role of IL-23, IL-17, and IL-22 in the pathogenesis of enthesitis [34,35].”
MethodThe Enthesis Organ Concept and Its Relevance to the Spondyloarthropathies
Benjamin, M., & McGonagle, D. (2009) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4419-0298-6_4 · Cited by 256 · cited 4×
“This organ consists of surrounding structures—fibrocartilage, bursa, fat pad, adjacent cancellous bone networks, and investing fascia—that functionally adapt in order to dissipate stress at the soft- and hard-tissue interface [23,24].”
BackgroundInfluentialThe enthesis: a review of the tendon-to-bone insertion
Apostolakos, J., Durant, T. J. S., Dwyer, C. R., Russell, R. P., Weinreb, J. H., Alaee, F., Beitzel, K., McCarthy, M. B., Cote, M. P., & Mazzocca, A. D. (2019) · Muscle Ligaments and Tendons Journal · doi:10.32098/mltj.03.2014.12 · Cited by 255 · cited 4×
“An enthesis is a location where the tendon, ligament, or joint capsule inserts into the bone to facilitate joint motion [9,10].”
BackgroundInfluentialReview: The Interleukin‐23/Interleukin‐17 Axis in Spondyloarthritis Pathogenesis: Th17 and Beyond
Smith, J. A., & Colbert, R. A. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38291 · Cited by 243
Sterry, W., Ortonne, J. ‐., Kirkham, B. W., Brocq, O., Robertson, D., Pedersen, R. D., Estojak, J., Molta, C. T., & Freundlich, B. (2010) · BMJ · doi:10.1136/bmj.c147 · Cited by 236
Mease, P. J., Gottlieb, A. B., van der Heijde, D., FitzGerald, O., Johnsen, A., Nys, M., Banerjee, S., & Gladman, D. D. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-210724 · Cited by 220
Terslev, L., Naredo, E., Iagnocco, A., Balint, P. V., Wakefield, R. J., Aegerter, P., Aydin, S. Z., Bachta, A., Hammer, H. B., Bruyn, G. A. W., et al. (2014) · Arthritis Care & Research · doi:10.1002/acr.22191 · Cited by 216
Self-citationBenham, H., Rehaume, L. M., Hasnain, S. Z., Velasco, J., Baillet, A. C., Ruutu, M., Kikly, K., Wang, R., Tseng, H., Thomas, G. P., et al. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38638 · Cited by 211 · cited 1×
“Additional studies using the SKG mouse models further support the role of IL-23, IL-17, and IL-22 in the pathogenesis of enthesitis [34,35].”
MethodCutolo, M., Myerson, G. E., Fleischmann, R. M., Lioté, F., Díaz-González, F., Van den Bosch, F., Marzo-Ortega, H., Feist, E., Shah, K., Hu, C., et al. (2016) · The Journal of Rheumatology · doi:10.3899/jrheum.151376 · Cited by 211
Review: Enthesitis: New Insights Into Pathogenesis, Diagnostic Modalities, and Treatment
Kehl, A. S., Corr, M., & Weisman, M. H. (2016) · Arthritis & Rheumatology · doi:10.1002/art.39458 · Cited by 199
Contribution of the IL-17/IL-23 axis to the pathogenesis of inflammatory bowel disease
Cătană, C.-S., Neagoe, I. B., Cozma, V., Magdaş, C., Tăbăran, F., & Dumitraşcu, D. L. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i19.5823 · Cited by 183 · cited 1×
“Further, IL-23 is upregulated in patients with active Crohn’s disease, a comorbidity associated with spondyloarthritis [14,32].”
BackgroundTan, A. L., Grainger, A. J., Tanner, S. F., Emery, P., & McGonagle, D. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21736 · Cited by 177
Differences in body mass index among individuals with PsA, psoriasis, RA and the general population
Bhole, V., Choi, H. K., Burns, L. C., Vera‐Kellet, C., Lacaille, D., Gladman, D. D., & Dutz, J. P. (2011) · Rheumatology · doi:10.1093/rheumatology/ker349 · Cited by 159 · cited 1×
“The BMI of patients with PsA, however, is higher versus the general population [97], and BMI is known to have a major impact on entheseal findings.”
BackgroundMease, P. J., Gottlieb, A. B., Berman, A., Drescher, E., Xing, J., Wong, R., & Banerjee, S. (2016) · Arthritis & Rheumatology · doi:10.1002/art.39700 · Cited by 152
Mease, P. J., Karki, C. K., Palmer, J. B., Etzel, C. J., Kavanaugh, A., Ritchlin, C. T., Malley, W., Herrera, V., Tran, M. L., & Greenberg, J. D. (2017) · Arthritis Care & Research · doi:10.1002/acr.23249 · Cited by 133 · cited 2×
“Patients with enthesitis have also demonstrated significantly poorer functional status as well as greater patient-reported pain and fatigue and were significantly more likely to experience overall impairment and impairment while working [59].”
BackgroundMethodTendon structure, disease, and imaging
Weinreb, J. H., Sheth, C. D., Apostolakos, J. M., McCarthy, M.-B., Barden, B. B., Cote, M. P., & Mazzocca, A. D. (2019) · Muscles Ligaments and Tendons Journal · doi:10.32098/mltj.01.2014.12 · Cited by 132 · cited 1×
“Additionally, US has the ability to image tendons under different levels of stress in a dynamic examination, it can scan all peripheral joints from a variety of angles, and it is relatively low cost [71,86].”
BackgroundAydın, S. Z., Karadağ, Ö., Filippucci, E., Atagündüz, P., Akdoğan, A., Kalyoncu, U., Grassi, W., & Di̇reskeneli̇, H. (2009) · Rheumatology · doi:10.1093/rheumatology/kep410 · Cited by 93
Sleep quality in patients with psoriatic arthritis
Gezer, O., Batmaz, İ., Sarıyıldız, M. A., Sula, B., Uçmak, D., Bozkurt, M., & Nas, K. (2014) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.12505 · Cited by 87 · cited 1×
“Further, in patients with PsA, enthesitis is significantly correlated with patient quality of life and sleep disturbance [60,61].”
BackgroundElyoussfi, S., Thomas, B. J., & Ciurtin, C. (2016) · Rheumatology International · doi:10.1007/s00296-016-3436-0 · Cited by 63 · cited 1×
“The ability of therapies that effectively treat enthesitis and potentially improve patients’ long-term outcomes makes accurate diagnosis and characterization of enthesitis increasingly important [54,55,62].”
BackgroundKristensen, S., Christensen, J. H., Schmidt, E. B., Olesen, J. L., Johansen, M. B., Arvesen, K. B., & Schlemmer, A. (2016) · Muscles Ligaments and Tendons Journal · doi:10.32098/mltj.02.2016.12 · Cited by 52 · cited 1×
“Clinical evaluations of entheses can detect tenderness and general soft-tissue swelling, but often are unable to identify more specific disease characteristics often associated with the pathology of enthesitis, such as tendon thickening, bursitis, bone erosions, enthesophytes, or calcifications [21,66].”
BackgroundEpidemiology of psoriatic arthritis
Catanoso, M., Pipitone, N., & Salvarani, C. (2012) · Reumatismo · doi:10.4081/reumatismo.2012.66 · Cited by 51 · cited 1×
“In almost 85% of patients, psoriasis will develop before PsA, but in 10–20% of patients, the symptoms will either appear concomitantly or the symptoms of PsA will precede those of psoriasis [4].”
BackgroundDiagnosis and treatment of enthesitis-related arthritis
Weiss, P. F. (2012) · Adolescent Health Medicine and Therapeutics · doi:10.2147/ahmt.s25872 · Cited by 48 · cited 1×
“An enthesis is a location where the tendon, ligament, or joint capsule inserts into the bone to facilitate joint motion [9,10].”
BackgroundMetabolic syndrome associated to non-inflammatory Achilles enthesopathy
Abate, M., Carlo, L. D., Salini, V., & Schiavone, C. (2014) · Clinical Rheumatology · doi:10.1007/s10067-014-2524-3 · Cited by 46 · cited 1×
“While enthesopathies can result from metabolic syndrome, these tend to occur at membranous entheses [11].”
BackgroundPsoriatic arthritis: complexities, comorbidities and implications for the clinic
Haroon, M., & FitzGerald, O. (2016) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2016.1139453 · Cited by 38 · cited 1×
“Moreover, the haplotype Bn27:05-Cn01:02 is associated with the presence of clinical enthesitis in PsA [29].”
BackgroundPsoriatic Arthritis for the Dermatologist
Tintle, S. J., & Gottlieb, A. B. (2014) · Dermatologic Clinics · doi:10.1016/j.det.2014.09.010 · Cited by 19 · cited 1×
“Although PsA may present at any point in a patient’s life, it most commonly occurs between the ages of 30 and 50 years [2,3].”
BackgroundMease, P. J. (2012) · The Journal of Rheumatology · doi:10.3899/jrheum.111237 · Cited by 9
Cited by
Chimenti, M. S., Sunzini, F., Fiorucci, L., Botti, E., Fonti, G. L., Conigliaro, P., Triggianese, P., Costa, L., Caso, F., Giunta, A., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02363 · Cited by 77
Yue, T., Ji, M., Qu, H., Guo, M., Bai, F., Zhang, Z., Wang, W., Gong, X., & Zhang, Z. (2019) · BMC Immunology · doi:10.1186/s12865-019-0297-9 · Cited by 19
Metadata
- Authors
- Kaeley, G. S., Eder, L., Aydin, S. Z., Gutierrez, M., & Bakewell, C.
- Venue
- Seminars in Arthritis and Rheumatism
- Publisher
- Elsevier BV
- Published
- 2018-08
- Volume
- 48
- Issue
- 1
- Pages
- 35-43
- ISSN
- 0049-0172 (ISSN-L)
- OpenAlex
- W2782126098
- Cited by
- 189
- References
- 51
- FWCI
- 17.80
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.